| 产品名称： | Dactylosporangium sp. |
|---|---|
| 商品货号： | TS186921 |
| Strain Designations： | SC 14051 |
| Application： | Produces dactylocycline A Produces dactylocycline B |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | 2°C to 8°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 196: Yeast malt extract agar ATCC® Medium 1877: ISP Medium 1 |
| Growth Conditions： | Temperature: 26.0°C Atmosphere:xa0 Aerobic |
| Name of Depositor： | E.R. Squibb & Sons, Inc. |
| U.S. Patent Number： | |
| References： | Wells JS, et al. Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. I. Taxonomy, production, isolation and biological activity. J. Antibiot. 45: 1892-1898, 1992. PubMed: 1490880 Tymiak AA, et al. Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. II. Structure elucidation. J. Antibiot. 45: 1899-1906, 1992. PubMed: 1490881 Devasthale PV, et al. Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. III. Absolute stereochemistry of the dactylocyclines. J. Antibiot. 45: 1907-1913, 1992. PubMed: 1490882 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Dactylosporangium sp. |
|---|---|
| 商品货号： | TS186921 |
| Strain Designations： | SC 14051 |
| Application： | Produces dactylocycline A Produces dactylocycline B |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | 2°C to 8°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 196: Yeast malt extract agar ATCC® Medium 1877: ISP Medium 1 |
| Growth Conditions： | Temperature: 26.0°C Atmosphere:xa0 Aerobic |
| Name of Depositor： | E.R. Squibb & Sons, Inc. |
| U.S. Patent Number： | |
| References： | Wells JS, et al. Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. I. Taxonomy, production, isolation and biological activity. J. Antibiot. 45: 1892-1898, 1992. PubMed: 1490880 Tymiak AA, et al. Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. II. Structure elucidation. J. Antibiot. 45: 1899-1906, 1992. PubMed: 1490881 Devasthale PV, et al. Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. III. Absolute stereochemistry of the dactylocyclines. J. Antibiot. 45: 1907-1913, 1992. PubMed: 1490882 |
